# argenx

**Source:** https://www.startuphub.ai/startups/argenx
**Profile type:** Startup

> Global immunology company developing antibody-based therapies for severe autoimmune diseases.

## About

Argenx is a global, commercial-stage biopharmaceutical company focused on developing and delivering transformative therapies for patients with severe autoimmune diseases. They leverage their expertise in immunology and antibody engineering to create a pipeline of novel antibody-based medicines, with a flagship product, Vyvgart (efgartigimod alfa), approved for conditions like generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.

## Key facts

- **Slug:** argenx
- **Website:** https://www.argenx.com/
- **Location:** Amsterdam, Netherlands
- **Founded:** 2008-04-25
- **Operating status:** Active
- **Total funding:** $51M
- **Sectors / tags:** BiTech, Biopharmaceuticals, Immunology, Drug Discovery, Antibody Therapeutics, Autoimmune Diseases, Clinical Trials, Pharmaceuticals

## Frequently asked

### What does argenx do?

Argenx is a global, commercial-stage biopharmaceutical company focused on developing and delivering transformative therapies for patients with severe autoimmune diseases. They leverage their expertise in immunology and antibody engineering to create a pipeline of novel antibody-based medicines, with a flagship product, Vyvgart (efgartigimod alfa), approved for conditions like generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.

### What is argenx's valuation?

StartupHub estimates argenx's effective valuation at $203.4M (range $127.8M to $306.6M, 10% confidence), based on comparable companies in the sector.

### How much funding has argenx raised?

argenx has raised a total of $51M in funding. The most recent round on record is Series B.

### Where is argenx headquartered?

argenx is headquartered in Amsterdam, Netherlands.

### When was argenx founded?

argenx was founded in 2008.

### What industry does argenx operate in?

argenx operates in BiTech, Biopharmaceuticals, Immunology, Drug Discovery, Antibody Therapeutics, Autoimmune Diseases.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "argenx",
          "item": "https://www.startuphub.ai/startups/argenx"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/argenx#webpage",
      "url": "https://www.startuphub.ai/startups/argenx",
      "name": "argenx - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of argenx. argenx is a startup founded in 2008, operating in BiTech and Biopharmaceuticals. Global immunology company developing antibody-based therapies for severe autoimmune diseases. Headquartered in Amsterdam, Netherlands.",
      "dateModified": "2026-07-10T06:35:12.069+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/argenx#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/argenx#organization",
      "name": "argenx",
      "url": "https://www.argenx.com/",
      "description": "This is the official profile of argenx. argenx is a startup founded in 2008, operating in BiTech and Biopharmaceuticals. Global immunology company developing antibody-based therapies for severe autoimmune diseases. Headquartered in Amsterdam, Netherlands.",
      "sameAs": [
        "https://www.startuphub.ai/startups/argenx"
      ],
      "foundingDate": "2008-04-25",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Amsterdam",
        "addressCountry": "Netherlands"
      },
      "knowsAbout": [
        "BiTech",
        "Biopharmaceuticals",
        "Immunology",
        "Drug Discovery",
        "Antibody Therapeutics",
        "Autoimmune Diseases",
        "Clinical Trials",
        "Pharmaceuticals"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/argenx#profile-assessment",
      "name": "argenx - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/argenx",
      "category": "BiTech",
      "description": "This is the official profile of argenx. argenx is a startup founded in 2008, operating in BiTech and Biopharmaceuticals. Global immunology company developing antibody-based therapies for severe autoimmune diseases. Headquartered in Amsterdam, Netherlands. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/argenx/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "argenx"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-10",
        "name": "argenx - Profile Score 49/100",
        "reviewBody": "This is the official profile of argenx. argenx is a startup founded in 2008, operating in BiTech and Biopharmaceuticals. Global immunology company developing antibody-based therapies for severe autoimmune diseases. Headquartered in Amsterdam, Netherlands. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/argenx/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 49,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```